Disease recurrence and progression remain as significant challenges for the management of non-muscle invasive bladder cancer (NMIBC). In recent years, novel drugs and delivery systems have been investigated as strategies to reduce recurrence, progression and mortality. In this review, we focus on the role of intravesical hyperthermic chemotherapy and discuss a novel approach involving a heat-activated drug delivery system (ThermoDox®) that enables local accumulation of systemic chemotherapy.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
drug delivery
8
recurrence progression
8
heat-targeted drug
4
delivery promising
4
promising approach
4
approach organsparing
4
organsparing treatment
4
treatment bladder
4
bladder cancerthermodox®
4
cancerthermodox® disease
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!